← SynDRA
LABETALOL
SynDRA canonical compound SYN0000129 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | Adrenergic receptor antagonist |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
- ADRA1D
- ADRB1
- ADRB2
- ADRA1A
- HTR1A
- SLC6A3
- SLC6A2
- SIGMAR1
- RCE1
- Htr1a
- HTR2B
- Adra1b
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRA1A ANTAGONIST
- ADRA2A ANTAGONIST
- ADRB1 ANTAGONIST
- ADRB2 ANTAGONIST
- ADRA2C ANTAGONIST
- ADRA1D ANTAGONIST
- ADRA1B ANTAGONIST
- ADRA2B ANTAGONIST
- ADRB3 ANTAGONIST
- ADRB2 PARTIAL AGONIST
Drug classes
- Adrenergic beta-Antagonists
- beta-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic alpha-1 Receptor Antagonists
- Adrenergic alpha-Antagonists
- Adrenergic Antagonists
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sympathomimetics
ATC classes
- C07A · BETA BLOCKING AGENTS
- BETA BLOCKING AGENTS AND THIAZIDES
- BETA BLOCKING AGENTS AND OTHER DIURETICS
Cross-references
Synonyms
- labetalol hydrochloride
- albetol
- ibidomide
- labetalol HCl
- SCH-19927
- Ibidomide
- Normozide
- AH-5158A FREE BASE
- SCH-15719W FREE BASE
- Albetol
- Labetalolum
- Labetolol
- NORMOZIDE
- AH-5158
- Labetalol (INN)
- Labetalol [INN:BAN]
- Labetalolum [INN-Latin]
- Normodyne (TN)
- Sch-19927
- Trandate (TN)
- 2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzamide
- 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide
- 2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide
- 3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol
- 5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide
- R5H8897N95
- CHEBI:6343
- CHEBI:167638
- labetalolo
- ApoLabetalol
- Apo Labetalol
- RefChem:58510
- DTXCID603191
- C07AG01
- AH5158
- MFCD00242941
- LABETALOL [INN]
- R,S-Labetalol
Reported adverse events
- Hypersensitivity
- Hypotension
- Dizziness
- Hepatic necrosis
- Nausea
- Dyspepsia
- Fatigue
- Vomiting
- Bradycardia
- Headache
- Vertigo
- Rash
Look up LABETALOL in the interactive SynDRA portal →